Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55K Hold
98
– – ﹤0.01% 1471
2026
Q1
$2.73K Hold
98
– – ﹤0.01% 1435
2025
Q4
$1.92K Buy
+98
New +$2.07K ﹤0.01% 1001
2025
Q3
– Sell
-77
Closed -$1.28K – 1345
2025
Q2
$1.28K Buy
77
+25
+48% +$418 ﹤0.01% 1048
2025
Q1
$857 Sell
52
-82
-61% -$1.59K ﹤0.01% 1142
2024
Q4
$2.61K Buy
134
+51
+61% +$1.24K ﹤0.01% 952
2024
Q3
$2.84K Hold
83
– – ﹤0.01% 931
2024
Q2
$3.22K Hold
83
– – ﹤0.01% 891
2024
Q1
$2.9K Hold
83
– – ﹤0.01% 889
2023
Q4
$2.52K Buy
+83
New +$2.45K ﹤0.01% 881
2023
Q3
– Sell
-39
Closed -$942 – 878
2023
Q2
$942 Buy
+39
New +$1.08K ﹤0.01% 955

Other funds holding TRMD

CVA Family Office's TRMD Position: Q2 2026 in Review

CVA Family Office held its TORM (TRMD) position steady in Q2 2026 at 98 shares worth $2.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1471.

CVA Family Office first reported a position in TRMD in Q2 2023 and has held it in 11 quarters since. The position peaked at $3.22K in Q2 2024. 151 funds tracked by Wall St. Rank hold TRMD as of Q2 2026.

  • CVA Family Office held 98 shares of TORM worth $2.55K as of Q2 2026.
  • CVA Family Office left its TORM share count unchanged in Q2 2026.
  • TORM made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1471 holding.
  • CVA Family Office first reported a position in TORM in Q2 2023 and has held it in 11 quarters since.
  • CVA Family Office's TORM position peaked at $3.22K in Q2 2024.
  • 151 funds tracked by Wall St. Rank held TORM as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.